Literature DB >> 30526629

Characterization of small genomic regions of the hepatitis B virus should be performed with more caution.

Lei Jia1, Fengyu Hu2, Hanping Li1, Lin Li1, Xiaoping Tang2, Yongjian Liu1, Haohui Deng2, Jingwan Han1, Jingyun Li3, Weiping Cai4.   

Abstract

BACKGROUND: Hepatitis B virus is a hepatotropic DNA virus that reproduces via an RNA intermediate. It can lead to an increased risk of serious liver diseases such as hepatocellular carcinoma and is a serious threat to public health. Currently, the HBV are designated based on greater than 8% nucleotide variation along the whole genome. The recombination of HBV is very common, a large majority of which are recombinants between 2 genotypes. The current work aims to characterize a suspected recombinant involving 3 genotypes.
METHODS: Fifty-seven HBV full-genome sequences were obtained from 57 patients co-infected with HBV and HIV-1 by amplification coupled with sequencing. JpHMM and RDP4 were used to perform recombination analysis respectively. The recombination results of a suspected 3-genotypic recombinant were further confirmed by both maximum likelihood phylogenetic tree and Mrbayes tree.
RESULTS: JpHMM recombination analysis clearly indicated one 3-genotypic HBV recombinant composing of B/C/D. The genotype assignments are supported by significant posterior probabilities. The subsequent phylogenetic analysis of sub-regions derived from inferred breakpoints led to a disagreement on the assignment of D segment. Investigating the conflict, further exploration by RDP4 and phylogenies revealed that the jpHMM-derived 3-genotypic recombinant is actually a B/C genotypic recombinant with C fragment spanning 1899 to 2295 (jpHMM) or 1821 to 2199 (RDP4).
CONCLUSIONS: The whole analysis indicated that (i) determination of small genomic regions should be performed with more caution, (ii) combinations of various recombination detection approaches conduce to obtain impartial results, and (iii) a unified system of nomenclature of HBV genotypes is necessary.

Entities:  

Keywords:  Genotypic recombination; Hepatitis B virus; JpHMM; RDP4

Mesh:

Substances:

Year:  2018        PMID: 30526629      PMCID: PMC6288937          DOI: 10.1186/s12985-018-1100-x

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


  46 in total

1.  Homologous recombination between different genotypes of hepatitis B virus.

Authors:  V Morozov; M Pisareva; M Groudinin
Journal:  Gene       Date:  2000-12-30       Impact factor: 3.688

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

Review 3.  Analyzing the mosaic structure of genes.

Authors:  J M Smith
Journal:  J Mol Evol       Date:  1992-02       Impact factor: 2.395

4.  Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan.

Authors:  Shaza Mahgoub; Daniel Candotti; Magdy El Ekiaby; Jean-Pierre Allain
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

5.  A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.

Authors:  L Stuyver; S De Gendt; C Van Geyt; F Zoulim; M Fried; R F Schinazi; R Rossau
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

6.  Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America.

Authors:  Patricia Arauz-Ruiz; Helene Norder; Betty H Robertson; Lars O Magnius
Journal:  J Gen Virol       Date:  2002-08       Impact factor: 3.891

7.  Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

Authors:  Xiaofeng Liang; Shengli Bi; Weizhong Yang; Longde Wang; Gang Cui; Fuqiang Cui; Yong Zhang; Jianhua Liu; Xiaohong Gong; Yuansheng Chen; Fuzhen Wang; Hui Zheng; Feng Wang; Jing Guo; Zhiyuan Jia; Jingchen Ma; Huaqing Wang; Huiming Luo; Li Li; Shuigao Jin; Stephen C Hadler; Yu Wang
Journal:  Vaccine       Date:  2009-09-01       Impact factor: 3.641

8.  MrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a large model space.

Authors:  Fredrik Ronquist; Maxim Teslenko; Paul van der Mark; Daniel L Ayres; Aaron Darling; Sebastian Höhna; Bret Larget; Liang Liu; Marc A Suchard; John P Huelsenbeck
Journal:  Syst Biol       Date:  2012-02-22       Impact factor: 15.683

9.  HBVdb: a knowledge database for Hepatitis B Virus.

Authors:  Juliette Hayer; Fanny Jadeau; Gilbert Deléage; Alan Kay; Fabien Zoulim; Christophe Combet
Journal:  Nucleic Acids Res       Date:  2012-11-03       Impact factor: 16.971

10.  Frequent intra-subtype recombination among HIV-1 circulating in Tanzania.

Authors:  Ireen E Kiwelu; Vladimir Novitsky; Lauren Margolin; Jeannie Baca; Rachel Manongi; Noel Sam; John Shao; Mary F McLane; Saidi H Kapiga; M Essex
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more
  3 in total

1.  Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences.

Authors:  Anna L McNaughton; Peter A Revill; Margaret Littlejohn; Philippa C Matthews; M Azim Ansari
Journal:  J Gen Virol       Date:  2020-03       Impact factor: 3.891

2.  Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinoma.

Authors:  Damien Cohen; Sumantra Ghosh; Yusuke Shimakawa; Njie Ramou; Pierre Simon Garcia; Anaëlle Dubois; Clément Guillot; Nora Kakwata-Nkor Deluce; Valentin Tilloy; Geoffroy Durand; Catherine Voegele; Gibril Ndow; Umberto d'Alessandro; Céline Brochier-Armanet; Sophie Alain; Florence Le Calvez-Kelm; Janet Hall; Fabien Zoulim; Maimuna Mendy; Mark Thursz; Maud Lemoine; Isabelle Chemin
Journal:  JHEP Rep       Date:  2020-07-11

3.  Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil.

Authors:  Ricardo Ariel Zimerman; Patrícia Aline Gröhs Ferrareze; Flavio Adsuara Cadegiani; Carlos Gustavo Wambier; Daniel do Nascimento Fonseca; Andrea Roberto de Souza; Andy Goren; Liane Nanci Rotta; Zhihua Ren; Claudia Elizabeth Thompson
Journal:  Front Med (Lausanne)       Date:  2022-02-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.